Stockreport

BioCardia to Present at December 2025 CSI Focus Devices in Heart Failure Congress

BioCardia, Inc.  (BCDA) 
PDF SUNNYVALE, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [NASDAQ: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of car [Read more]